Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fesco launches scheduled flights from Vietnam to Russia

4/11/24 FESH

Novatek's gas sales volume in Q1 decreased by 3.8%

4/11/24 NVTK

Angara-A5 launched from Vostochny Cosmodrome

4/11/24 RKKE

EuroTrans opened the first window of acceptance of the OTC offer

4/11/24 EUTR

Yandex wants to install Yandex Auto on Chinese cars

4/11/24 YNDX

Yandex testing service for cloud gaming

4/11/24 YNDX

Softline completed an additional exchange of Noventiq receipts

4/11/24 SOFL

CEO of ICPAO Yandex Artem Savinovsky appointed

4/11/24 YNDX

Gazprom Neft migrated to Astra Linux for 85% employees

4/11/24 ASTR

Board of Directors of Rosbank recommended dividends

4/10/24 ROSB